Equity
€615,977 ▲ 66.4%
Equity rose in 2025 from €370,071 to €615,977.
ELNOMALO
Lifetime
4 annual accounts with figures on one time axispeak €337,851 (2025)
€337,851▲ 4.9%
peak €245,906 (2025)
€245,906▲ 5.7%
peak €615,977 (2025)
€615,977▲ 66.4%
€29,987▼ 51.6%
Board2 names since 2022
1 director
Documentsfilings and deeds
24-06-202637 days before the deadline
2025micro format
Equity from €370,071 to €615,977Debts from €61,990 to €29,987Cash from €181,665 to €45,931
Key points
from the 2025 annual accountsTurnover
≈ €510,000 estimated
The micro format states no turnover.
Liquidity
34.79 was 9.42 in 2024
Short-term debts fell from €33,917 to €15,667.
Filings
4 annual accounts 1 late
The 2022 accounts came 60 days late. The other three were filed on time.
Board
1 joined
New director. Latest change 05-05-2026 · 2 in office.
Position in the sector
€245,906
Higher net result than 92% of companies in human health. Sector median €59,563 · 21,309 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 3,135 companies had the same profile as ELNOMALO has now. Each dot stands for 8 companies, two years later.
97.0%
were still trading
2.1%
stopped another way
0.8%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,135 companies, not a prediction for ELNOMALO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 15-09-2022
Director
- 60 sharesdeed of 20-09-2022
Recent changes
Appointment: (director)
General meeting of 05-05-2026 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0790876236
Incorporation
Founding capital of €6,000, 60 shares · Founder: · Appointment: (director) · published on 20-09-2022 · Gazette deed
First establishment
Roelsstraat 21, Koksijde
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| ELNOMALO Koksijde | €645,964 | €337,851 | 95.4% | - |
| Dr. Emilie Acx Oostkamp | €607,766 | €333,940 | 86.5% | - |
| DR. ALEXANDER VERHAEGHE Knokke-Heist | €662,454 | €366,304 | 91.6% | - |
| WILDHA Bruges | €697,728 | €318,063 | 96.2% | - |
| Dr. Sofie De Meulder Bruges | €604,773 | €307,560 | 75.4% | - |
| Dr. Emmanuel De Tandt Zuienkerke | €556,654 | €345,472 | 67.0% | - |
| VIVID VISION Bruges | €717,223 | €380,213 | 95.1% | - |
These companies have the same main activity as ELNOMALO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €557,000 and €717,000, founded in 2022.
Official details
Source: KBO- Status
- Active since 16-09-2022Normal situation
- Activity
- Specialist medical practiceNACE 86220and 3 others
- Establishment unit
- 2.336.787.1118670 Koksijde, since 16-09-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 19-11-2025
Annual accounts 2025
- €645,964▲ 49.5%
- Filing
- Filed on 24-06-2026, 37 days before the end of the filing period
Insights on ELNOMALO
ELNOMALO files the micro format. That format states no turnover. The gross margin rose from €26,738 in 2022 to €337,851 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about ELNOMALO
- What is the company number of ELNOMALO?
- The company number of ELNOMALO is 0790.876.236. The VAT number is the same number with BE in front: BE 0790.876.236.
- Where is ELNOMALO based?
- The registered office is at Roelsstraat 21, 8670 Koksijde.Company details
- What does ELNOMALO do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of ELNOMALO?
- ELNOMALO is a private limited company (BV).
- When was ELNOMALO founded?
- ELNOMALO was founded on 16-09-2022.
- Is ELNOMALO still active?
- Yes, ELNOMALO is an active enterprise in the KBO register.
- What is the turnover of ELNOMALO?
- The turnover in financial year 2025 is ≈ €510,000. This figure is estimated from the gross margin of €337,851 and 31 comparable companies (NACE 86220). It probably lies between €450,000 and €710,000.Financials
- Is ELNOMALO profitable?
- In financial year 2025, ELNOMALO made a profit of €245,906.
- Where can I find the annual accounts of ELNOMALO?
- ELNOMALO filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of ELNOMALO due?
- ELNOMALO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.